Clinical Trials Logo

Post-ischemic Stroke clinical trials

View clinical trials related to Post-ischemic Stroke.

Filter by:
  • None
  • Page 1

NCT ID: NCT02422940 Terminated - Clinical trials for Post-ischemic Stroke

An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study

Start date: April 2015
Phase: Phase 3
Study type: Interventional

This is an extension study to evaluate the long-term safety, tolerability, and efficacy of two dose strengths of dalfampridine-ER twice daily tablets when administered for at least 12 months to subjects with chronic post-ischemic stroke walking deficits who have completed the controlled, double-blind Study DALF-PS-1016.

NCT ID: NCT02271217 Completed - Clinical trials for Post-Ischemic Stroke

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.

Start date: December 2014
Phase: Phase 3
Study type: Interventional

The objective of this study is to determine the effect of two dose strengths of dalfampridine-Extended Release (ER) tablets, taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.